Experience in the use of clobazam in the treatment of Lennox-Gastaut syndrome

Therapeutic Advances in Neurological Disorders

Volumn 7, Issue 3, 2014, Pages 169-176

  Purcarin, Gabriela ^a   Ng, Y Tze ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

benzodiazepine; clobazam; drop seizures; Lennox Gastaut syndrome; open label trial; pediatric epilepsy

Indexed keywords

CLOBAZAM;

CLINICAL STUDY; CONSTIPATION; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERSALIVATION; INTRACTABLE EPILEPSY; LENNOX GASTAUT SYNDROME; LETHARGY; LONG TERM CARE; OPEN STUDY; PRIORITY JOURNAL; REVIEW; SEIZURE; SOMNOLENCE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 84899427851     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285614521314     Document Type: Review

References (27)

1. Arzimanoglou A. French J. Blume W. Cross J. Ernst J. Feucht M. et al. (2009) Lennox–Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 8: 82–93.
2. Canadian Clobazam Cooperative Group (1991) Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Epilepsia 32: 407–416.
3. Commission on Classification and Terminology of the International League Against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30: 389–399.
4. Conry J. Ng Y. Paolicchi J. Kernitsky L. Mitchell W. Ritter F. et al. (2009) Clobazam in the treatment of Lennox–Gastaut syndrome. Epilepsia 50: 1158–1166.
5. Cramer J. Sapin C. François C. (2013) Indirect comparison of clobazam and other therapies for Lennox–Gastaut syndrome. Acta Neurol Scand 128: 91–99.
6. Crumrine P. (2011) Management of seizures in Lennox–Gastaut syndrome. Paediatr Drugs 13: 107–118.
7. da Silveira M. Montenegro M. Franzon R. Guerreiro C. Guerreiro M. (2006) Effectiveness of clobazam as add-on therapy in children with refractory focal epilepsy. Arq Neuropsiquiatr 64: 705–710.
8. Glauser T. Kluger G. Sachdeo R. Krauss G. Perdomo C. Arroyo S. (2008) Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome. Neurology 70: 1950–1958.
9. Giarratano M. Standley K. Benbadis S. (2012) Clobazam for treatment of epilepsy. Expert Opin Pharmacother 13: 227–233.
10. Hancock E. Cross H. (2009) Treatment of Lennox–Gastaut syndrome. Cochrane Database Syst Rev 8: CD003277.
11. Jensen P. (1994) Felbamate in the treatment of Lennox–Gastaut syndrome. Epilepsia 35(Suppl. 5): 54–57.
12. Leahy J. Chu-Shore C. Fisher J. (2011) Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome. Neuropsychiatr Dis Treat 7: 673–681.
13. Lemmon M. Kossoff E. (2013) New treatment options for Lennox–Gastaut syndrome. Curr Treat Options Neurol 15: 519–528.
14. Lundbeck, Inc. (2011) ONFI (clobazam) [prescribing information]. Deerfield, IL: Lundbeck, Inc. Available at: http://www.lundbeck.com/upload/us/files/pdf/Products/Onfi_PI_US_EN.pdf (accessed 14 January 2014).
15. Ng Y. Collins S. (2007) Clobazam. Neurotherapeutics 4: 138–144.
16. Ng Y. Conry J. Drummond R. Stolle J. Weinberg M. for the OV-1012 Study Investigators (2011) Randomized, phase III study results of clobazam in Lennox–Gastaut syndrome. Neurology 77: 1473–1481.
17. Ng Y. Conry J. Paolicchi J. Kernitsky L. Mitchell W. Drummond R. et al. (2012) Long-term safety and efficacy of clobazam for Lennox–Gastaut syndrome: 2-year results of an open-label extension study. Epilepsy Behav 25: 687–694.
18. Rudolph U. Crestani F. Benke D. Brünig I. Benson J. Fritschy J. et al. (1999) Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401: 796–800.
19. Sachdeo R. Glauser T. Ritter F. Reife R. Lim P. Pledger G. (1999) A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome: Topiramate YL Study Group. Neurology 52: 1882–1887.
20. Sankar R. (2012) GABAA receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. CNS Drugs 26: 229–244.
21. Seif-Eddeine H. Ng Y. (2012) Clobazam for patients with Lennox–Gastaut syndrome and epilepsy. Expert Rev Neurother 12: 385–393.
22. Silva R. Montenegro M. Geurreiro C. Geurreiro M. (2006) Clobazam as add-on therapy in children with epileptic encephalopathy. Can J Neurol Sci 33: 209–213.
23. Steru L. Chermat R. Millet B. Mico J. Simon P. (1986) Comparative study in mice of ten 1,4-benzodiazepines and of clobazam: anticonvulsant, anxiolytic, sedative, and myorelaxant effects. Epilepsia 27(Suppl. 1): S14–S17.
24. The Felbamate Study Group in Lennox–Gastaut Syndrome (1993) Efficacy of felbamate in childhood epileptic encephalopathy (Lennox–Gastaut syndrome). N Engl J Med 328: 29–33.
25. VanStraten A. Ng Y. (2012) Update on the management of Lennox–Gastaut syndrome. Pediatr Neurol 47: 153–161.
26. Walzer M. Bekersky I. Blum R. Tolbert D. (2012) Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P 450 isoenzymes. Pharmacotherapy 32: 340–353.
27. Wheless J. Phelps S. (2013) Clobazam: a newly approved but well-established drug for the treatment of intractable epilepsy syndromes. J Child Neurol 28: 219–229.